BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 21933103)

  • 1. The hypomethylation agent bisdemethoxycurcumin acts on the WIF-1 promoter, inhibits the canonical Wnt pathway and induces apoptosis in human non-small-cell lung cancer.
    Liu YL; Yang HP; Zhou XD; Gong L; Tang CL; Wang HJ
    Curr Cancer Drug Targets; 2011 Nov; 11(9):1098-110. PubMed ID: 21933103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypomethylation effects of curcumin, demethoxycurcumin and bisdemethoxycurcumin on WIF-1 promoter in non-small cell lung cancer cell lines.
    Liu YL; Yang HP; Gong L; Tang CL; Wang HJ
    Mol Med Rep; 2011; 4(4):675-9. PubMed ID: 21484077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Norcantharidin inhibits Wnt signal pathway via promoter demethylation of WIF-1 in human non-small cell lung cancer.
    Xie J; Zhang Y; Hu X; Lv R; Xiao D; Jiang L; Bao Q
    Med Oncol; 2015 May; 32(5):145. PubMed ID: 25814287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of Wnt signaling by the miR-29 family is mediated by demethylation of WIF-1 in non-small-cell lung cancer.
    Tan M; Wu J; Cai Y
    Biochem Biophys Res Commun; 2013 Sep; 438(4):673-9. PubMed ID: 23939044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promoter demethylation of WIF-1 by epigallocatechin-3-gallate in lung cancer cells.
    Gao Z; Xu Z; Hung MS; Lin YC; Wang T; Gong M; Zhi X; Jablon DM; You L
    Anticancer Res; 2009 Jun; 29(6):2025-30. PubMed ID: 19528461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Procaine and procainamide inhibit the Wnt canonical pathway by promoter demethylation of WIF-1 in lung cancer cells.
    Gao Z; Xu Z; Hung MS; Lin YC; Wang T; Gong M; Zhi X; Jablons DM; You L
    Oncol Rep; 2009 Dec; 22(6):1479-84. PubMed ID: 19885602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Norcantharidin blocks Wnt/β-catenin signaling via promoter demethylation of WIF-1 in glioma.
    Xie D; Xie J; Wan Y; Ma L; Qi X; Wang K; Yang S
    Oncol Rep; 2016 Apr; 35(4):2191-7. PubMed ID: 26781164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Wnt Inhibitory Factor-1 in Inhibition of Bisdemethoxycurcumin Mediated Epithelial-to-Mesenchymal Transition in Highly Metastatic Lung Cancer 95D Cells.
    Xu JH; Yang HP; Zhou XD; Wang HJ; Gong L; Tang CL
    Chin Med J (Engl); 2015 May; 128(10):1376-83. PubMed ID: 25963361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wnt inhibitory factor-1 is silenced by promoter hypermethylation in human lung cancer.
    Mazieres J; He B; You L; Xu Z; Lee AY; Mikami I; Reguart N; Rosell R; McCormick F; Jablons DM
    Cancer Res; 2004 Jul; 64(14):4717-20. PubMed ID: 15256437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indirubin inhibits Wnt/β-catenin signal pathway via promoter demethylation of WIF-1.
    Liu SG; Luo GP; Qu YB; Chen YF
    BMC Complement Med Ther; 2020 Aug; 20(1):250. PubMed ID: 32795328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent epigenetic inactivation of Wnt inhibitory factor-1 in human gastrointestinal cancers.
    Taniguchi H; Yamamoto H; Hirata T; Miyamoto N; Oki M; Nosho K; Adachi Y; Endo T; Imai K; Shinomura Y
    Oncogene; 2005 Nov; 24(53):7946-52. PubMed ID: 16007117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/beta-catenin signaling pathway.
    Urakami S; Shiina H; Enokida H; Kawakami T; Tokizane T; Ogishima T; Tanaka Y; Li LC; Ribeiro-Filho LA; Terashima M; Kikuno N; Adachi H; Yoneda T; Kishi H; Shigeno K; Konety BR; Igawa M; Dahiya R
    Clin Cancer Res; 2006 Jan; 12(2):383-91. PubMed ID: 16428476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wnt inhibitory factor-1 functions as a tumor suppressor through modulating Wnt/β-catenin signaling in neuroblastoma.
    Zhang J; Zhou B; Liu Y; Chen K; Bao P; Wang Y; Wang J; Zhou Z; Sun X; Li Y
    Cancer Lett; 2014 Jun; 348(1-2):12-9. PubMed ID: 24561119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular activation of Wnt signaling through epigenetic dysregulation of Wnt inhibitory factor-1 (Wif-1) is associated with pathogenesis of adrenocortical tumor.
    Mitsui Y; Yasumoto H; Nagami T; Hiraki M; Arichi N; Ishikawa N; Araki A; Maruyama R; Tanaka Y; Dahiya R; Shiina H
    Oncotarget; 2014 Apr; 5(8):2198-207. PubMed ID: 24755523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional significance of Wnt inhibitory factor-1 gene in kidney cancer.
    Kawakami K; Hirata H; Yamamura S; Kikuno N; Saini S; Majid S; Tanaka Y; Kawamoto K; Enokida H; Nakagawa M; Dahiya R
    Cancer Res; 2009 Nov; 69(22):8603-10. PubMed ID: 19887605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promoter hypermethylation of Wnt inhibitory factor-1 in patients with lung cancer: A systematic meta-analysis.
    Zheng Y; Li X; Jiang Y; Xu Y; Song B; Zhou Q; Liang X; Yang X
    Medicine (Baltimore); 2016 Dec; 95(49):e5433. PubMed ID: 27930522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant promoter methylation of WIF-1 and SFRP1, 2, 4 genes in mesothelioma.
    Kohno H; Amatya VJ; Takeshima Y; Kushitani K; Hattori N; Kohno N; Inai K
    Oncol Rep; 2010 Aug; 24(2):423-31. PubMed ID: 20596629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wnt inhibitory factor-1 gene transfer inhibits melanoma cell growth.
    Lin YC; You L; Xu Z; He B; Yang CT; Chen JK; Mikami I; Clément G; Shi Y; Kuchenbecker K; Okamoto J; Kashani-Sabet M; Jablons DM
    Hum Gene Ther; 2007 Apr; 18(4):379-86. PubMed ID: 17472570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Garcinol inhibits cancer stem cell-like phenotype via suppression of the Wnt/β-catenin/STAT3 axis signalling pathway in human non-small cell lung carcinomas.
    Huang WC; Kuo KT; Adebayo BO; Wang CH; Chen YJ; Jin K; Tsai TH; Yeh CT
    J Nutr Biochem; 2018 Apr; 54():140-150. PubMed ID: 29414668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of WIF-1 and Wnt5a expression is related to aggressiveness of sporadic breast cancer in Tunisian patients.
    Trifa F; Karray-Chouayekh S; Jmal E; Jmaa ZB; Khabir A; Sellami-Boudawara T; Frikha M; Daoud J; Mokdad-Gargouri R
    Tumour Biol; 2013 Jun; 34(3):1625-33. PubMed ID: 23417837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.